Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders

This effort aims to stimulate research in a major gap area in pediatric psychopharmacology for psychiatric and neurodevelopmental disorders, by encouraging the development of objective pediatric central nervous system (CNS) measures that can be incorporated into pharmacologic trials.